Literature DB >> 22009753

HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.

Takaya Ishihara1, Jun Inoue1, Ken-Ichi Kozaki2, Issei Imoto1, Johji Inazawa3.   

Abstract

LAPTM5 (lysosomal-associated protein multispanning transmembrane 5) is a membrane protein on the intracellular vesicles. We have previously demonstrated that the accumulation of LAPTM5-positive vesicles was closely associated with the programmed cell death occurring during the spontaneous regression of neuroblastomas. Although the accumulation of LAPTM5 protein might occur at the post-translational level, the molecular mechanism has been unclear. Here, we found that the level of LAPTM5 protein is regulated negatively by the degradation through ubiquitination by ITCH, an E3 ubiquitin ligase. ITCH directly binds to the PPxY motif of LAPTM5 via its WW domains and promotes ubiquitination through a HECT-type ligase domain. Overexpression of ITCH led to the degradation of LAPTM5 protein, and conversely, knockdown of ITCH by siRNA resulted in the stabilization of LAPTM5 protein. In addition, the inhibition of ITCH enhanced the cell death occurred by accumulation of LAPTM5 in neuroblastoma cells. These findings suggest that LAPTM5 is a novel substrate in terms of degradation by the ubiquitin ligase ITCH, and this system might act as a negative regulator in the spontaneous regression of neuroblastomas by preventing LAPTM5-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009753      PMCID: PMC3243552          DOI: 10.1074/jbc.M111.251694

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.

Authors:  Adriano Marchese; Camilla Raiborg; Francesca Santini; James H Keen; Harald Stenmark; Jeffrey L Benovic
Journal:  Dev Cell       Date:  2003-11       Impact factor: 12.270

Review 2.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Endocytosis: One ubiquitin does the trick.

Authors:  Rachel David
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02-09       Impact factor: 94.444

4.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Authors:  W L Perry; C M Hustad; D A Swing; T N O'Sullivan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase.

Authors:  L Qiu; C Joazeiro; N Fang; H Y Wang; C Elly; Y Altman; D Fang; T Hunter; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation.

Authors:  Pingzhao Zhang; Chenji Wang; Kun Gao; Dejie Wang; Jun Mao; Jian An; Chen Xu; Di Wu; Hongxiu Yu; Jun O Liu; Long Yu
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

7.  ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization.

Authors:  Takaya Ishihara; Hitoshi Tsuda; Akiko Hotta; Ken-Ichi Kozaki; Akira Yoshida; Jaeduk Yoshimura Noh; Koichi Ito; Issei Imoto; Johji Inazawa
Journal:  Cancer Sci       Date:  2008-10       Impact factor: 6.716

Review 8.  Neuroblastoma: biology and molecular and chromosomal pathology.

Authors:  Manfred Schwab; Frank Westermann; Barbara Hero; Frank Berthold
Journal:  Lancet Oncol       Date:  2003-08       Impact factor: 41.316

9.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Authors:  Zaidoun Salah; Gerry Melino; Rami I Aqeilan
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

10.  Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination.

Authors:  Youngshil Pak; Wioletta K Glowacka; M Christine Bruce; Nam Pham; Daniela Rotin
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

View more
  8 in total

1.  Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.

Authors:  Alessia Bellomaria; Gaetano Barbato; Gerry Melino; Maurizio Paci; Sonia Melino
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

2.  LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.

Authors:  Ying Wang; Jun Liu; Chizuru Akatsu; Runyun Zhang; Hai Zhang; Han Zhu; Kangwei Liu; Han-Ying Zhu; Qing Min; Xin Meng; Chaoqun Cui; Yue Tang; Meiping Yu; Yaxuan Li; Xiaoqian Feng; Hao Wei; Zichao Wen; Sihan Ji; Martin G Weigert; Takeshi Tsubata; Ji-Yang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

3.  miR-34b/c regulates doxorubicin-induced myocardial cell injury through ITCH.

Authors:  Wen-Cai Zhang; Jin-Hua Yang; Guang-Hui Liu; Fan Yang; Jun-Long Gong; Meng-Ge Jia; Meng-Juan Zhang; Luo-Sha Zhao
Journal:  Cell Cycle       Date:  2019-10-18       Impact factor: 4.534

4.  High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.

Authors:  M Rossi; B Rotblat; K Ansell; I Amelio; M Caraglia; G Misso; F Bernassola; C N Cavasotto; R A Knight; A Ciechanover; G Melino
Journal:  Cell Death Dis       Date:  2014-05-01       Impact factor: 8.469

5.  Down-regulation of LAPTM5 in human cancer cells.

Authors:  Michelle Nuylan; Tatsuyuki Kawano; Johji Inazawa; Jun Inoue
Journal:  Oncotarget       Date:  2016-05-10

6.  Lysosomal-associated transmembrane protein 5 (LAPTM5) is a molecular partner of CD1e.

Authors:  Catherine Angénieux; François Waharte; Alexandre Gidon; François Signorino-Gelo; Virginie Wurtz; Rim Hojeij; Fabienne Proamer; Christian Gachet; Alain Van Dorsselaer; Daniel Hanau; Jean Salamero; Henri de la Salle
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

7.  Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.

Authors:  Ganna Chornokur; Hui-Yi Lin; Jonathan P Tyrer; Kate Lawrenson; Joe Dennis; Ernest K Amankwah; Xiaotao Qu; Ya-Yu Tsai; Heather S L Jim; Zhihua Chen; Ann Y Chen; Jennifer Permuth-Wey; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova; Fiona Bruinsma; Elisa V Bandera; Yukie T Bean; Matthias W Beckmann; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A Brinton; Angela Brooks-Wilson; Clareann H Bunker; Ralf Butzow; Ian G Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Andreas du Bois; Evelyn Despierre; Ed Dicks; Jennifer A Doherty; Thilo Dörk; Matthias Dürst; Douglas F Easton; Diana M Eccles; Robert P Edwards; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Marc T Goodman; Jacek Gronwald; Patricia Harrington; Philipp Harter; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Peter Hillemanns; Claus K Hogdall; Estrid Hogdall; Satoyo Hosono; Anna Jakubowska; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Linda E Kelemen; Mellissa Kellar; Lambertus A Kiemeney; Camilla Krakstad; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashi Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Boon Kiong Lim; Jolanta Lissowska; Karen Lu; Jan Lubinski; Lene Lundvall; Leon F A G Massuger; Keitaro Matsuo; Valerie McGuire; John R McLaughlin; Iain McNeish; Usha Menon; Roger L Milne; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; Ursula Eilber; Kunle Odunsi; Sara H Olson; Irene Orlow; Sandra Orsulic; Rachel Palmieri Weber; James Paul; Celeste L Pearce; Tanja Pejovic; Liisa M Pelttari; Malcolm C Pike; Elizabeth M Poole; Harvey A Risch; Barry Rosen; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Eva Schernhammer; Ira Schwaab; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa C Southey; Beata Spiewankiewicz; Lara Sucheston; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Lotte Thomsen; Ingvild L Tangen; Shelley S Tworoger; Anne M van Altena; Robert A Vierkant; Ignace Vergote; Christine S Walsh; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Anna H Wu; Xifeng Wu; Yin-Ling Woo; Hannah Yang; Wei Zheng; Argyrios Ziogas; Hanis N Hasmad; Andrew Berchuck; Edwin S Iversen; Joellen M Schildkraut; Susan J Ramus; Ellen L Goode; Alvaro N A Monteiro; Simon A Gayther; Steven A Narod; Paul D P Pharoah; Thomas A Sellers; Catherine M Phelan
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

8.  HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Akira Funayama; Shunsuke Netsu; Yuki Honda; Taro Narumi; Shinpei Kadowaki; Hiromasa Hasegawa; Shintaro Honda; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Hideaki Kamata; Osamu Nakajima; Isao Kubota
Journal:  J Am Heart Assoc       Date:  2016-01-21       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.